The discrepancies in CD40 expression between NB cell lines and fresh tumour cells may be related to the presence of in vivo factors (e.g. IFN-γ) capable of upregulating surface CD40 in the tumour microenvironment. This evidence concerns the gene IFNG and neoplasm.